To test the hypothesis that pharmacologic COX-2 inhibition prevents or slows schwannoma growth, we performed a chemopreventative trial of celecoxib in Nf2f/f;PostnCre+ mice beginning at 3-5 weeks of age, before the initiation of Schwann cell hyperplasia or frank schwannoma formation. The gene discussed is PTGS2; the disease is schwannoma.